Further evidence for the contribution of the vascular endothelial growth factor gene in coronary artery disease susceptibility

Gene

Volumn 521, Issue 2, 2013, Pages 217-221

  Cui, Q T ^a   Li, Y ^a   Duan, C H ^a   Zhang, W ^a   Guo, X L ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Coronary artery disease; Single nucleotide polymorphisms; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

5' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876962136     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.03.091     Document Type: Article

References (36)

1. Amoli M.M., Amiri P., Alborzi A., Larijani B., Saba S., Tavakkoly-Bazzaz J. VEGF gene mRNA expression in patients with coronary artery disease. Mol. Biol. Rep. 2012, 39:8595-8599.
2. Biselli P.M., Guerzoni A.R., de Godoy M.F., Pavarino-Bertelli E.C., Goloni-Bertollo E.M. Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population. Heart Vessels 2008, 23:371-375.
3. Blumberg H.P., et al. Influence of vascular endothelial growth factor variation on human hippocampus morphology. Biol. Psychiatry 2008, 64:901-903.
4. Brogan I.J., Khan N., Isaac K., Hutchinson J.A., Pravica V., Hutchinson I.V. Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum. Immunol. 1999, 60:1245-1249.
5. Celletti F.L., Waugh J.M., Amabile P.G., Brendolan A., Hilfiker P.R., Dake M.D. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat. Med. 2001, 7:425-429.
6. Douvaras P., et al. Association of VEGF gene polymorphisms with the development of heart failure in patients after myocardial infarction. Cardiology 2009, 114:11-18.
7. Evans A., et al. The genetics of coronary heart disease: the contribution of twin studies. Twin Res. 2003, 6:432-441.
8. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997, 18:4-25.
9. Fischer M., et al. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 2005, 111:855-862.
10. Hendel R.C., et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation 2000, 101:118-121.
11. Henry T.D., et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003, 107:1359-1365.
12. Kucukardali Y., et al. The relationship between severity of coronary artery disease and plasma level of vascular endothelial growth factor. Cardiovasc. Revasc. Med. 2008, 9:66-70.
13. Lee S.H., Wolf P.L., Escudero R., Deutsch R., Jamieson S.W., Thistlethwaite P.A. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 2000, 342:626-633.
14. Lee K.W., Lip G.Y., Blann A.D. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004, 110:2355-2360.
15. Lemstrom K.B., et al. Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Circulation 2002, 105:2524-2530.
16. Lin T.H., et al. Vascular endothelial growth factor polymorphisms and extent of coronary atherosclerosis in Chinese population with advanced coronary artery disease. Am. J. Hypertens. 2010, 23:960-966.
17. Lin T.H., et al. Functional vascular endothelial growth factor gene polymorphisms and diabetes: effect on coronary collaterals in patients with significant coronary artery disease. Clin. Chim. Acta 2010, 411:1688-1693.
18. Marsh S., et al. Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy. Diabetes Care 2000, 23:1375-1380.
19. Mayer B., Erdmann J., Schunkert H. Genetics and heritability of coronary artery disease and myocardial infarction. Clin. Res. Cardiol. 2007, 96:1-7.
20. Moulton K.S., et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4736-4741.
21. Ogawa H., et al. Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction. Cardiology 2000, 93:93-99.
22. Okrainec K., Banerjee D.K., Eisenberg M.J. Coronary artery disease in the developing world. Am. Heart J. 2004, 148:7-15.
23. Pastuszczak M., et al. The +405 GG variant of vascular endothelial growth factor polymorphism is associated with poor prognosis in patients undergoing coronary artery bypass graft surgery. Pol. Arch. Med. Wewn. 2009, 119:719-725.
24. Petrovic D. The role of vascular endothelial growth factor gene as the genetic marker of atherothrombotic disorders and in the gene therapy of coronary artery disease. Cardiovasc. Hematol. Agents Med. Chem. 2010, 8:47-54.
25. Petrovic D., Verhovec R., Globocnik Petrovic M., Osredkar J., Peterlin B. Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes. Cardiology 2007, 107:291-295.
26. Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J. Vasc. Res. 2000, 37:443-448.
27. Shah S.H., et al. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol. Syst. Biol. 2009, 5:258.
28. Simari R.D., O'Brien T. Clinical trials in vascular gene therapy: the missing piece of the puzzle. Arch. Pathol. Lab. Med. 2002, 126:317-319.
29. Sobti R.C., Maithil N., Thakur H., Sharma Y., Talwar K.K. VEGF and IL-4 gene variability and its association with the risk of coronary heart disease in north Indian population. Mol. Cell. Biochem. 2010, 341:139-148.
30. Szeto C.C., Chow K.M., Poon P., Szeto C.Y., Wong T.Y., Li P.K. Genetic polymorphism of VEGF: impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients. Kidney Int. 2004, 65:1947-1955.
31. Vale P.R., et al. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 2000, 102:965-974.
32. van der Meer P., et al. The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy. J. Card. Fail. 2005, 11:279-284.
33. Vincenti V., Cassano C., Rocchi M., Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996, 93:1493-1495.
34. Watson C.J., Webb N.J., Bottomley M.J., Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000, 12:1232-1235.
35. Young H.S., et al. Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. J. Invest. Dermatol. 2006, 126:453-459.
36. Zhao Q., et al. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 2002, 105:1110-1115.